Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes - an 8-year prospective cohort study
- PMID: 32567151
- DOI: 10.1111/aos.14487
Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes - an 8-year prospective cohort study
Abstract
Purpose: To investigate the time-sequential correlations between progression/remission of diabetic kidney disease (DKD) and development of diabetic retinopathy (DR) or diabetic macular oedema (DME) in type 2 diabetes (T2D).
Methods: This was an 8-year prospective cohort study in which 576 patients with T2D and microalbuminuria from one medical centre in Taiwan were recruited. Progression of microalbuminuria was defined as shift of urinary albumin/creatinine ratio (ACR) into 300 mg/g or more; remission of microalbuminuria was defined as having a urinary ACR less than 30 mg/g in at least two of three tests over a period of 6 months. Cox regression analysis was used to evaluate the hazard ratios (HRs) for progression or remission of microalbuminuria on development of any DR, proliferative DR (PDR) and DME.
Results: After adjusting for baseline characteristics , remission of microalbuminuria was a significant protecting factor for development of PDR (HR = 0.290, 95% CI: 0.102-0.826, p = 0.020) and DME (HR = 0.404, 95% CI: 0.188-0.864, p = 0.020). After further adjustment for the mean follow-up HbA1c and systolic blood pressure, remission of microalbuminuria was still a significant protecting factor for development of PDR (HR = 0.348, 95% CI: 0.122-0.992, p = 0.048).
Conclusions: Remission of microalbuminuria was an independent protecting factor for development of PDR and DME. Aggressive treatment for DKD might help prevent the progression of DR.
Keywords: diabetes mellitus; diabetic kidney disease; diabetic macular edema; diabetic retinopathy.
© 2020 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Similar articles
-
Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.JAMA Ophthalmol. 2018 Jan 1;136(1):68-74. doi: 10.1001/jamaophthalmol.2017.5202. JAMA Ophthalmol. 2018. PMID: 29167896 Free PMC article.
-
Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.Ophthalmol Retina. 2018 Jan;2(1):38-45. doi: 10.1016/j.oret.2017.05.010. Epub 2017 Aug 9. Ophthalmol Retina. 2018. PMID: 31047300
-
Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.Clin Exp Ophthalmol. 2020 May;48(4):470-476. doi: 10.1111/ceo.13728. Epub 2020 Feb 26. Clin Exp Ophthalmol. 2020. PMID: 32065699
-
Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.JAMA Ophthalmol. 2017 Jun 1;135(6):586-593. doi: 10.1001/jamaophthalmol.2017.0988. JAMA Ophthalmol. 2017. PMID: 28472362 Free PMC article. Review.
-
Therapeutic management of diabetic kidney disease.J Diabetes Investig. 2011 Aug 2;2(4):248-54. doi: 10.1111/j.2040-1124.2011.00112.x. J Diabetes Investig. 2011. PMID: 24843492 Free PMC article. Review.
Cited by
-
Renal impairment may indicate postoperative low vision in young patients with proliferative diabetic retinopathy undergoing vitrectomy.Front Endocrinol (Lausanne). 2024 Jan 11;14:1321226. doi: 10.3389/fendo.2023.1321226. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38274226 Free PMC article.
-
Ocular Manifestations in Head and Neck Cancer: A Cross-Sectional Study from a Tertiary Care Centre from South India.Rom J Ophthalmol. 2023 Oct-Dec;67(4):345-353. doi: 10.22336/rjo.2023.55. Rom J Ophthalmol. 2023. PMID: 38239414 Free PMC article.
-
Short-term duration of diabetic retinopathy as a predictor for development of diabetic kidney disease.J Transl Int Med. 2023 Dec 20;11(4):449-458. doi: 10.2478/jtim-2022-0074. eCollection 2023 Dec. J Transl Int Med. 2023. PMID: 38130638 Free PMC article.
-
Retinal microvascular changes in diabetic patients with diabetic nephropathy.BMC Endocr Disord. 2023 May 5;23(1):101. doi: 10.1186/s12902-022-01250-w. BMC Endocr Disord. 2023. PMID: 37147636 Free PMC article.
-
The relationship between renal function and diabetic retinopathy in patients with type 2 diabetes: A three-year prospective study.Heliyon. 2023 Mar 25;9(4):e14662. doi: 10.1016/j.heliyon.2023.e14662. eCollection 2023 Apr. Heliyon. 2023. PMID: 37095916 Free PMC article.
References
-
- Ahmad J (2015): Management of diabetic nephropathy: recent progress and future perspective. Diabetes Metab Syndr 9: 343-358.
-
- Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A & Koya D (2005): Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 54: 2983-2987.
-
- Avery RL, Castellarin AA, Steinle NC et al. (2014): Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol 98: 1636-1641.
-
- Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS & Kim NH (2004): Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol 183: 183-194.
-
- Chen H, Zheng Z, Huang Y et al. (2012): A Microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One 7: e36718.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical